FrancophonIA/ELRC3.0 huggingface dataset:
English: Flatulence, abdominal distension, gastro-oesophageal reflux, constipation, dry
Danish: Flatulens, abdominal udspiling, gastrooesophageal refluks, obstipation, mundtørhed, gastritis
English: (24 h), days 1, 15;
Danish: (24 timer), dag 4;
English: VCR 2 mg i.v., days 6, 13, 20; Daunorubicin 45 mg/m i.v., days 6-7, 13-14
Danish: Daunorubicin 45 mg/m² i.v., dag 6-7, 13
English: The dose is 800 mg per day, to be taken as 1 capsule of 400 mg in the morning and 1 capsule of
Danish: • Hvis du behandles for DSFP: Dosis er 800 mg pr. dag, der skal tages som 1 kapsel med 400 mg om morgenen og 1 kapsel
English: The starting dose is 100 mg, to be taken as 1 capsule of 100 mg once a day.
Danish: • Hvis du behandles for HES/CEL: Startdosis er 100 mg, som skal tages som 1 kapsel med 100 mg én gang dagligt.
English: Three (3) patients with HES and CEL associated with PDGFR gene re-arrangements were reported in 3 publications.
Danish: I tre publikationer var der rapporteret om tre (3) patienter med HES og CEL forbundet med PDGFR-omlejring.
English: Imatinib medac 100 mg hard capsules Size “3” hard capsules with orange body and cap. Imatinib medac 400 mg hard capsules Size “00” hard capsules with caramel body and cap.
Danish: Imatinib medac 100 mg hårde kapsler Hårde kapsler str. ”3” med orange under- og overdel.
English: Imatinib medac 100 mg hard capsules Capsule content
Danish: Imatinib medac 100 mg hårde kapsler Kapselindhold
English: Imatinib medac 400 mg hard capsules Capsule content
Danish: Imatinib medac 400 mg hårde kapsler Kapselindhold
English: (0.5 h), days 7, 8, 14, 15; i.v., days 22-25, 29-32
Danish: (0,5 time), dag 7, 8, 14,
English: In the juvenile toxicology study, effects upon growth, delay in vaginal opening and preputial separation were observed at approximately 0.3 to 2 times the average paediatric exposure at the highest recommended dose of 340 mg/m2.
Danish: 0,3-2 gange den gennemsnitlige pædiatriske eksponering ved den højest anbefalede dosis på 340 mg/m².
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each hard capsule contains 100 mg of imatinib (as mesilate).
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver hårde kapsel indeholder 100 mg imatinib (som mesilat).
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each hard capsule contains 400 mg of imatinib (as mesilate).
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver hårde kapsel indeholder 400 mg imatinib (som mesilat).
English: Neoplasm benign, malignant and unspecified (including cysts and polyps)
Danish: Reaktivering af hepatitis B* Benigne, maligne og uspecificerede tumorer (inkl.
English: The starting dose is 400 mg, to be taken as 1 capsule of 400 mg once a day.
Danish: • Hvis du behandles for MDS/MPD: Startdosis er 400 mg, som skal tages som 1 kapsel med 400 mg én gang dagligt.
English: Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription (such as paracetamol) and including herbal medicines (such as St. John's Wort).
Danish: Dette gælder også medicin, som ikke er købt på recept (såsom paracetamol), inklusive naturlægemidler (såsom perikon).
English: A further 162 patients with HES/CEL, reported in 35 published case reports and case series received imatinib at doses from 75 mg to 800 mg daily.
Danish: Yderligere er 162 patienter med HES/CEL i alderen 11 til 78 år omtalt i 35 publicerede kasuistikker og behandlingsserier.
English: Patients with severe renal impairment should be treated with caution.
Danish: Der bør udvises forsigtighed ved behandling af patienter med svært nedsat nyrefunktion.
English: The age of these patients ranged from 25 to 72 years.
Danish: Patienternes alder varierede fra 25 til
English: How to store Imatinib medac
Danish: Hvis du har glemt at tage Imatinib medac
English: Haemorrhagic corpus luteum/haemorrhagic ovarian cyst General disorders and administration site conditions Very common: Fluid retention and oedema, fatigue
Danish: Hæmoragisk corpus luteum/ hæmoragisk ovariecyste Almene symptomer og reaktioner på administrationsstedet
English: During treatment with Imatinib medac, tell your doctor straight away if you put on weight very quickly.
Danish: Brug af anden medicin sammen med Imatinib medac Fortæl altid lægen, på apoteket eller sygeplejersken, hvis du tager anden medicin eller har gjort det for nylig.
English: Occurrences of severe fluid retention (pleural effusion, oedema, pulmonary oedema, ascites, superficial oedema) have been reported in approximately 2.5 % of newly diagnosed CML patients taking imatinib.
Danish: Hos ca. 2,5 % af nyligt diagnosticerede CML-patienter i behandling med imatinib er der rapporteret tilfælde af svær væskeretention (pleuraekssudat, ødem, pulmonalt ødem, ascites, perifert ødem).
English: days 3-5;
Danish: ): dag 1-5
English: Patients were treated at doses of imatinib of 260 mg/m2/day
Danish: De blev behandlet med imatinib i doser fra 75 mg til 800 mg dagligt.
English: • Discharge from the eye with itching, redness and swelling (conjunctivitis), watery eyes or
Danish: • Flåd fra øjet med kløe, rødme og hævelse (betændelse af øjets bindehinde), øget tåreflåd eller
English: medac
Danish: DFSP
English: Methotrexate (5 g/m over 24 hours, IV): days 1 and 15 at hour 36, IV; 15 mg/m
Danish: Methotrexat (5 g/m² over 24 timer, i.v.
English: Ara-C 2x 2 g/m i.v.
Danish: IDA 8 mg/m² i.v.
English: 9/l, then resume treatment at 300 mg.
Danish: 9/l og trombocytter ≥20 x 10 9/l og genoptag herefter behandlingen med 300 mg.
English: i.v., days 1-3, 15-16; VCR 2 mg total dose i.v., days 1, 8, 15, 22;
Danish: VCR 2 mg total dose i.v., dag 1, 8, 15, 22; CP 750 mg/m² i.v., dag 1, 8;
English: Yellow iron oxide (E172) Titanium dioxide (E171) Red iron oxide (E172)
Danish: Gul jernoxid (E 172) Titandioxid (E 171) Rød jernoxid (E 172)
English: Renal pain, haematuria, renal failure acute, urinary frequency increased
Danish: Nyresmerter, hæmaturi, akut nyresvigt, øget vandladningsfrekvens
English: Yellow iron oxide (E172) Titanium dioxide (E171) Red iron oxide (E172) Black iron oxide (E172)
Danish: Gul jernoxid (E 172) Titandioxid (E 171) Rød jernoxid (E 172) Sort jernoxid (E 172)
English: MTX 15 mg intrathecal, days 1, 8, 15, 22;
Danish: MTX 15 mg intrathecal, dag 1, 8, 15, 22; Ara-C 40 mg intrathecal, dag 1, 8, 15, 22; Methylprednisolon 40 mg intrathecal, dag 1, 8, 15, 22
English: (1 h) days 4-5;
Danish: (3 timer), dag 1-4;
English: VCR (1.5 mg/m 2/day, IV): days 1, 29
Danish: VCR (1,5 mg/m²/dag, i.v.
English: • Bruising.
Danish: • Udslæt.
English: Read the package leaflet before use.
Danish: ANVENDELSESMÅDE OG ADMINISTRATIONSVEJ(E) Læs indlægssedlen inden brug.
English: chronic myeloid leukaemia (CML) for whom bone marrow transplantation is not considered as
Danish: • børn med nydiagnosticeret Philadelphia-kromosom (bcr-abl) positiv (Ph+) kronisk myeloid leukæmi (CML), for hvilke knoglemarvstransplantation ikke anses for førstevalgsbehandling.
English: Remission induction DEX 10 mg/m oral, days 6-7, 13-16; i.v.
Danish: DEX 10 mg/m² oral, dag 6-7, 13-16; VCR 1 mg i.v., dag 7, 14;
English: 9/l, no blood blasts, BM blasts < 5 % and no extramedullary disease] NEL: Same criteria as for CHR but ANC ≥ 1 x 10
Danish: NEL: Samme kriterier som for CHR, men ANC ≥1 x 10
English: Your doctor will discuss with you the possible risks of taking Imatinib medac during
Danish: Dette vil hjælpe med at beskytte dig mod maveproblemer, når du tager Imatinib medac.
English: The recommended dose of imatinib is 600 mg/day for adult patients with Ph+ ALL.
Danish: Den anbefalede dosis af imatinib er 600 mg/dag til voksne patienter med Ph+ ALL.Gennem alle faser af omsorgen bør behandlingen overvåges af hæmatologiske eksperter, som er ansvarlige for denne sygdom.
English: Liver dysfunction
Danish: Tumorlysesyndrom
English: (3 h), days 1-4; Mitoxantrone 10 mg/m i.v.
Danish: (3 timer), dag 1; Daunorubicin 60 mg/m² i.v.
English: The recommended dose of imatinib is 100 mg/day for patients with HES/CEL.
Danish: Dosering ved HES/CEL hos voksne patienter Den anbefalede dosis af imatinib er 100 mg/dag til voksne patienter med HES/CEL.
English: Tumour lysis syndrome
Danish: Blod og lymfesystem
English: What Imatinib medac looks like and contents of the pack Imatinib medac 100 mg hard capsules are gelatin capsules of size “3” with orange body and cap. Imatinib medac 400 mg hard capsules are gelatin capsules of size “00” with caramel body and cap. Imatinib medac 100 mg capsules are supplied in packs containing 60 capsules in blisters.
Danish: Imatinib medac 100 mg hårde kapsler er gelatinekapsler i størrelse ”3” med orange over- og underdel.
English: terfenadine, bortezomib, docetaxel and quinidine).
Danish: gastric antral vascular ectasia (GAVE)*
English: Triple IT therapy (age-adjusted): days 1 and 22 2/day, IV): days 22-26 2/day, IV): days 22-26 2/day, IV): days 22-26 G-CSF (5 μg/kg, SC): days 27-36 or until ANC > 1500 post nadir 2, q12h, IV): days 43, 44 2, IM): day 44
Danish: G-CSF (5 μg/kg, s.c.): dag 27-36, eller indtil ANC >1500 post nadir ARA-C (3 g/m², q12h, i.v.
English: However if it is nearly time for the next
Danish: Men hvis det næsten er tid til at tage den næste dosis, skal du springe den glemte dosis over.
English: The dose can be reduced if not tolerated (see sections 4.4, 4.8 and 5.2).
Danish: 4.4, 4.8 og 5.2).
English: Prednisolone 200 mg oral, 5 days per month for 13 months All treatment regimens include administration of steroids for CNS prophylaxis.
Danish: månedligt i 13 måneder; Prednisolon 200 mg oral, 5 dag per måned i 13 måneder
English: Consolidation therapy DEX 10 mg/m oral, days 1-5; Vindesine 3 mg/m i.v., day 1;
Danish: VCR 1,3 g/m² i.v., dag 1; Prednisolon 60 mg/m² oral, dag 1-5
English: Induction-consolidation therapy i.v.
Danish: = intravenøs, s.c. = subkutan, i.t.
English: over 24 hours, IV): days 1 and 15 at hour 36, IV; 15 mg/m
Danish: (24 timer), dag 1, 15; 6-MP 25 mg/m² oral, dag 1-20
English: Eye irritation, eye pain, orbital oedema, scleral haemorrhage, retinal haemorrhage, blepharitis, macular oedema
Danish: Øjenirritation, øjensmerter, orbitalt ødem, sclerablødning, retinablødning,
English: (1 h), days 1-5; i.v.
Danish: (1 time), dag 1-3;
English: 2/day PO): days 1-5; 29-33 6-MP (75 mg/m 2/day, PO): days 8-28 Methotrexate (20 mg/m 2/week, PO): days 8, 15, 22
Danish: (1 time) dag 1; Ara-C 60 mg/m² i.v., dag 22-25, 29-32
English: Depending on the condition being treated, the patients can also be given other medicines.
Danish: Afhængigt af den sygdom, der behandles, kan patienterne også gives andre lægemidler.
English: MabThera received a marketing authorisation valid throughout the EU on 2 June 1998.
Danish: MabThera fik en markedsføringstilladelse med gyldighed i hele EU den 2. juni 1998.
English: Further information on MabThera can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/mabthera.
Danish: Yderligere information om MabThera findes på agenturets websted under: ema.europa.eu/medicines/human/EPAR/mabthera.
English: As for all medicines, data on the use of MabThera are continuously monitored.
Danish: Som for alle lægemidler bliver data vedrørende brugen af MabThera løbende overvåget.
English: A second study in 117 patients looked at the proportion of patients whose condition came back within 28 months.
Danish: I et andet studie hos 117 patienter så man nærmere på andelen af patienter, hvis sygdom vendte tilbage inden for 28 måneder.
English: Other information about MabThera
Danish: Andre oplysninger om MabThera
English: Patients with blood cancers can switch to an injection given under the skin after they have received one full dose of the infusion.
Danish: Patienter med blodkræft kan skifte til en injektion under huden, efter at de har fået en komplet dosis af infusionen.
English: What measures are being taken to ensure the safe and effective use of MabThera?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af MabThera?
English: The formulation injected under the skin must also not be used in patients who are allergic to a substance called hyaluronidase.
Danish: Formuleringen, der injiceres under huden, må heller ikke anvendes hos patienter, som er allergiske over for et stof, der kaldes hyaluronidase.
English: ‘Autoimmune' means that the disease is caused by the immune system (the body's natural defences) attacking the body's own cells.
Danish: at sygdommen er forårsaget af immunsystemet (kroppens naturlige forsvar), der angriber kroppens egne celler.
English: In addition, the medicine should be given under the close supervision of an experienced healthcare professional and in an environment where facilities for resuscitating patients are immediately available.
Danish: Desuden bør lægemidlet gives under tæt overvågning af en erfaren sundhedsperson på et sted, hvor genoplivningsudstyr er umiddelbart tilgængeligt.
English: These patients are also to receive an alert card, which they are to carry at all times, instructing them to contact their doctor immediately if they experience symptoms of infection.
Danish: Disse patienterne skal desuden have udleveret et påmindelseskort, som de altid skal have på sig, og som angiver, at de straks skal kontakte lægen, hvis de får symptomer på infektion.
English: Some results from the main studies on the benefits of MabThera are described below:
Danish: Nogle af resultaterne fra hovedstudier om fordelene ved MabThera beskrives i det følgende:
English: An overview of MabThera and why it is authorised in the EU
Danish: En oversigt over MabThera, og hvorfor det er godkendt i EU
English: All doctors administering MabThera under the skin will also receive educational material to minimise the risk of improper use or errors.
Danish: Alle læger, der anvender MabThera til injektion under huden, vil også modtage oplysningsmateriale for at minimere risikoen for forkert brug eller fejl.
English: MabThera contains the active substance rituximab.
Danish: MabThera indeholder det aktive stof rituximab.
English: Before each infusion or injection, the patient should be given an antihistamine (to prevent allergic reactions) and an anti-pyretic (a medicine for fever).
Danish: Før hver infusion eller injektion bør patienten gives et lægemiddel mod allergiske reaktioner (et antihistamin) og et antipyretikum (febernedsættende middel).
English: The European Medicines Agency decided that MabThera's benefits are greater than its risks and recommended that it be given marketing authorisation.
Danish: Det Europæiske Lægemiddelagentur konkluderede, at fordelene ved MabThera opvejer risiciene, og anbefalede udstedelse af markedsføringstilladelse for MabThera.
English: Why is MabThera authorised in the EU?
Danish: Hvorfor er MabThera godkendt i EU?
English: Side effects reported with MabThera are carefully evaluated and any necessary action taken to protect patients.
Danish: De indberettede bivirkninger ved MabThera vurderes omhyggeligt, og der tages de nødvendige forholdsregler for at beskytte patienterne.
English: The company that markets MabThera will also submit reports from a study on the effectiveness of MabThera in previously diagnosed pemphigus vulgaris patients and on the long-term effects of the medicine on the progression of the disease.
Danish: Den virksomhed, som markedsfører MabThera, vil også indsende rapporter fra et studie af virkningen af MabThera hos tidligere diagnosticerede pemfigus vulgaris-patienter og af lægemidlets langtidsvirkninger på sygdommens udvikling.
English: What is MabThera and what is it used for?
Danish: Hvad er MabThera, og hvad anvendes det til?
English: Studies show MabThera to be effective in treating all the conditions for which it is approved.
Danish: Studier viser, at MabThera er effektivt til at behandle alle de sygdomme, som det er godkendt til.
English: Depending on the condition it is used to treat, MabThera may be given on its own, or with chemotherapy, methotrexate or a corticosteroid.
Danish: Alt efter hvilken sygdom det anvendes til at behandle, kan MabThera gives alene eller sammen med kemoterapi, methotrexat eller et kortikosteroid.
English: For more information about using MabThera, see the package leaflet or contact your doctor or pharmacist.
Danish: Hvis du ønsker mere information om anvendelsen af MabThera, kan du læse indlægssedlen eller kontakte lægen eller apotekspersonalet.
English: A maintenance study in previously untreated patients showed the likelihood for the disease to get worse was reduced by 50% for patients who received MabThera.
Danish: Et vedligeholdelsesstudie hos tidligere ubehandlede patienter viste, at sandsynligheden for forværring af sygdommen blev reduceret med 50 % hos patienter, der fik MabThera.
English: The active substance in MabThera, rituximab, is a monoclonal antibody designed to recognise and attach to a protein called CD20 present on the surface of B-lymphocytes.
Danish: Det aktive stof i MabThera, rituximab, er et monoklonalt antistof, som er opbygget til at kunne genkende og binde sig til et protein kaldet CD20, som findes på overfladen af B-lymfocytter.
English: MabThera is given as an infusion (drip) into a vein.
Danish: MabThera gives som en infusion (drop) i en vene.
English: Patients with rheumatoid arthritis, GPA, MPA or pemphigus must not receive MabThera if they have severe heart problems.
Danish: Patienter med rheumatoid arthritis, GPA, MPA eller pemfigus må heller ikke få MabThera, hvis de har svære hjerteproblemer.
English: Following 2 years of treatment, 90% of patients treated with MabThera and shortterm (up to 6 months) prednisone were in complete remission (meaning that skin and mucosa had healed and there were no new or old lesions) after stopping prednisone for 2 months or more, compared with 28% of patients treated with prednisone alone.
Danish: Efter 2 års behandling kunne der hos 90 % af de patienter, der blev behandlet med MabThera og kortvarigt (op til 6 måneder) med prednison, påvises fuldstændig remission (dvs. at hud og slimhinder var helet, og at der ingen nye eller gamle læsioner var) efter ophør med prednison i 2 måneder eller derover sammenlignet med 28 % af de patienter, der blev behandlet med prednison alene.
English: What is the risk associated with MabThera?
Danish: Hvilken risiko er der forbundet med MabThera?
English: In GPA and MPA, destroying the B-lymphocytes lowers the production of antibodies thought to play an important role in attacking the blood vessels and causing inflammation.
Danish: Ved GPA og MPA fører ødelæggelsen af B-cellerne til nedsat dannelse af antistoffer, der menes at spille en vigtig rolle ved at angribe blodkarrene og forårsage inflammation.
English: When rituximab attaches to CD20, it causes the death of B-lymphocytes, which helps in lymphoma and CLL (where B-lymphocytes have become cancerous) and in rheumatoid arthritis (where B-lymphocytes are involved in joint inflammation).
Danish: Når rituximab bindes til CD20, dør B-lymfocytterne, hvilket hjælper ved lymfomer og CLL (hvor Blymfocytter er blevet angrebet af kræft) og ved reumatoid artritis (hvor B-lymfocytterne er involveret i inflammation i leddene).
English: MabThera is a medicine used to treat the following blood cancers and inflammatory conditions:
Danish: MabThera er et lægemiddel til behandling af voksne med følgende former for blodkræft og betændelsestilstande:
English: MabThera must not be used in people who are hypersensitive (allergic) to rituximab, mouse proteins or any of the other ingredients or in patients with a severe infection or a severely weakened immune system.
Danish: MabThera må ikke anvendes til patienter, der er overfølsomme (allergiske) over for rituximab, museproteiner eller andre af indholdsstofferne eller til patienter med svær infektion eller alvorligt svækket immunsystem.
English: The most common side effects with MabThera intravenous infusions are reactions related to the infusion (such as fever, chills and shivering) while most common serious side effects are infusion reactions, infections and heart-related problems.
Danish: De mest almindelige bivirkninger ved intravenøse infusioner med MabThera er reaktioner i forbindelse med infusionen (f.eks. feber, kuldegysninger og kulderystelser), og de mest almindelige alvorlige bivirkninger er reaktioner på infusionen, infektioner og hjerteproblemer.
English: • follicular lymphoma and diffuse large B cell non-Hodgkin's lymphoma (two types of non-Hodgkin's lymphoma, a blood cancer);
Danish: • follikulært lymfom og diffust storcellet B-celle-non-Hodgkin-lymfom (to former for non-Hodgkin lymfom, en type blodkræft)
English: • moderate to severe pemphigus vulgaris, an autoimmune disease characterised by widespread blistering and erosion of the skin and mucous membranes (the linings of internal organs).
Danish: • moderat til svær pemfigus vulgaris, en autoimmun sygdom, der er kendetegnet ved udbredt blæredannelse og erosion af hud og slimhinder (de indre organers vægge).
English: • chronic lymphocytic leukaemia (CLL, another blood cancer affecting white blood cells);
Danish: • kronisk lymfatisk leukæmi (CLL, en anden type blodkræft, der påvirker hvide blodlegemer)
English: Similar side effects are seen when MabThera is injected under the skin, with the exception of reactions around the injections site (pain, swelling and rash), which occur more frequently with the skin injections.
Danish: Lignende bivirkninger ses, når MabThera injiceres under huden, med undtagelse af reaktioner på injektionsstedet (smerte, hævelse og udslæt), som forekommer hyppigere ved hudinjektioner.
English: • In a study of 90 patients newly diagnosed with pemphigus, rituximab in combination with prednisone (a corticosteroid) was shown to be more effective than prednisone alone at clearing skin lesions.
Danish: • I et studie hos 90 patienter med nydiagnosticeret pemfigus viste rituximab i kombination med prednison (et kortikosteroid) sig at være mere effektivt end prednison alene til heling af hudlæsioner.
English: • In a study of 517 patients with rheumatoid arthritis, MabThera was more effective than placebo: 51% of the patients receiving MabThera had an improvement in symptoms, compared with 18% of the patients receiving placebo.
Danish: • I et studie af 517 patienter med reumatoid artritis var MabThera også mere effektivt end placebo: 51 % af de patienter, der fik MabThera, havde en forbedring i symptomerne sammenlignet med 18 % af de patienter, der fik placebo.
English: The company marketing MabThera will provide doctors and patients using the medicine for rheumatoid arthritis, GPA, MPA or pemphigus with educational material on the risk of infection including of a rare severe infection known as progressive multifocal leukoencephalopathy (PML).
Danish: Virksomheden, der markedsfører MabThera, vil udlevere oplysningsmateriale til læger og patienter, der anvender lægemidlet til behandling af rheumatoid artrit, GPA, MPA eller pemfigus, om risikoen for infektion, herunder om en sjælden alvorlig infektion kaldet multifokal leukoencefalopati (PML).
English: MabThera is available as a concentrate that is made up into the solution for infusion and as a readymade solution for the injection under the skin.
Danish: MabThera fås som et koncentrat, der tilberedes til en opløsning til infusion og som en brugsklar opløsning til injektion under huden.
English: • In a study of 198 patients with GPA or MPA, 64% of patients given MabThera were in complete remission after six months, compared with 55% given cyclophosphamide, a comparator medicine.
Danish: • I et studie af 198 patienter med GPA eller MPA opnåede 64 % af de patienter, der blev behandlet med MabThera, fuldstændig remission efter seks måneder sammenlignet med 55 % af dem, der fik cyclofosfamid, et sammenligningslægemiddel.
English: For the full list of side effects of MabThera, see the package leaflet.
Danish: Den fuldstændige liste over bivirkninger ved MabThera fremgår af indlægssedlen.
English: • severe rheumatoid arthritis (an inflammatory condition of the joints);
Danish: • svær reumatoid artritis (en inflammatorisk (betændelse) tilstand i leddene)
English: How is MabThera used?
Danish: Hvordan anvendes MabThera?
English: What benefits of MabThera have been shown in studies?
Danish: Hvilke fordele viser studierne, at der er ved MabThera?